Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03795753 · ClinicalTrials.gov registry record · NA
Determining the Benefits of Improving Communication in BPAP/CPAP Users
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT03795753 is a NA study that has completed, run by Emory University. The registered enrollment target is 36 participants.
The verdict
NCT03795753, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of a non-invasive communication aid for BPAP/CPAP masks. This study also looks to determine the potential impact of the device on patients with obstructive sleep apnea (OSA) and the individuals that interact with the device.
Interventions
- DEVICE F2S Communicator
- OTHER Non-functioning Communicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2019-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03795753
The ClinicalTrials.gov registry entry for NCT03795753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which F2S Communicator is the first listed.
NCT03795753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03795753 about?
NCT03795753 is a clinical study titled "Determining the Benefits of Improving Communication in BPAP/CPAP Users". The purpose of this study is to determine the effectiveness of a non-invasive communication aid for BPAP/CPAP masks. This study also looks to determine the potential impact of the device on patients with obstructive sleep apnea (OSA) and the individuals that interact with the device.
What is the current status of trial NCT03795753?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2019-03-22. Estimated completion is 2019-07-08.
What interventions are being tested in trial NCT03795753?
The interventions under investigation include: F2S Communicator (DEVICE), Non-functioning Communicator (OTHER).
Who is sponsoring clinical trial NCT03795753?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.